BIO-RAD LABORATORIES -CL B (BIO.B)

US0905721082 - Common Stock

279.91  -58.64 (-17.32%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
2.923B
14.81%		2.802B
-4.12%		2.671B
-4.67%		2.721B
1.86%
EBITDA
YoY % growth
N/AN/AN/A497.76M
EBIT
YoY % growth
564.7M
34.04%		486.8M
-13.79%		365.696M
-24.88%		364.68M
-0.28%
Operating Margin
19.32%17.37%13.69%13.40%
EPS
YoY % growth
15.67
48.81%		14.23
-9.19%		11.77
-17.29%		10.80
-8.20%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		2.17
-35.12%
Revenue
Q2Q % growth		625.28M
-7.61%
EBITDA
Q2Q % growth		94.794M
EBIT
Q2Q % growth		58.768M
-22.16%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 3.10
-6.34%		2.850.258.96%
Q3 2023
Q2Q % growth		 2.33
-10.38%		2.81-0.48-17.09%
Q2 2023
Q2Q % growth		 3.00
-11.24%		2.710.2910.88%
Q1 2023
Q2Q % growth		 3.34
-32.39%		3.58-0.24-6.64%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 681.184M
-6.73%		691.94M-10.756M-1.55%
Q3 2023
Q2Q % growth		 632.1M
-7.15%		696.46M-64.36M-9.24%
Q2 2023
Q2Q % growth		 681.1M
-1.45%		704.94M-23.84M-3.38%
Q1 2023
Q2Q % growth		 676.8M
-3.33%		696.73M-19.93M-2.86%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-13.35% -30.44% 0% -9.01%
Revenue0% -5.67% 0% -0.98%